Expand NBY Menu
NBY MENU

NBY Stock Summary and Trading Ideas (Novabay Pharmaceuticals | AMEX:NBY)

Charts for Today's Stock Price and Implied Volatility in Novabay Pharmaceuticals

19-Apr-2024

Stock Price & Volume | Full Chart

Sentiment

Trading Statistics

Key Ratios

Novabay Pharmaceuticals (NBY) Frequently Asked Questions

What does Novabay Pharmaceuticals do?

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

What symbol and exchange does Novabay Pharmaceuticals stock trade?

Novabay Pharmaceuticals trades on the AMEX stock market under the symbol NBY.

What is Novabay Pharmaceuticals stock price doing today?

As of April 19, 2024, NBY stock price was flat at $0.08 with 1,406,814 million shares trading.

What is Novabay Pharmaceuticals's Beta?

NBY has a beta of 0.77, meaning it tends to be less sensitive to market movements. NBY has a correlation of 0.02 to the broad based SPY ETF.

How much is Novabay Pharmaceuticals worth?

NBY has a market cap of $2.48 million. This is considered a Sub-Micro Cap stock.

How much money does Novabay Pharmaceuticals make?

Last quarter Novabay Pharmaceuticals reported $4 million in Revenue and -$.21 earnings per share. This beat revenue expectation by $327,000 and exceeded earnings estimates by $.09.

What is the highest and lowest price Novabay Pharmaceuticals traded in the last 3 year period?

In the last 3 years, NBY stock traded as high as $30.70 and as low as $.07.

What are the top ETFs holding Novabay Pharmaceuticals?

The top ETF exchange traded funds that NBY belongs to (by Net Assets): VXF.

Is Novabay Pharmaceuticals (NBY) a good investment?

NBY has underperformed the market in the last year with a price return of -95.2% while the SPY ETF gained +21.2%. NBY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -45.8% and -21.2%, respectively, while the SPY returned +4.3% and -3.5%, respectively.

What is the support and resistance for Novabay Pharmaceuticals (NBY) stock price?

NBY support price is $.08 and resistance is $.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NBY stock will trade within this expected range on the day.